RESUMO
The Expert Panel for Cosmetic Ingredient Safety (Panel) reviewed the safety of inorganic hydroxides, which function in cosmetics primarily as pH adjusters. Representatives from the cosmetic industry have indicated these ingredients are used in depilating and hair waving/straightening formulations to raise pH values. The Panel considered relevant data related to these ingredients. The Panel concluded that these inorganic hydroxides are safe in hair straighteners and depilatories under conditions of recommended use; users should minimize skin contact. These ingredients are safe for all other present practices of use and concentration described in this safety assessment when formulated to be nonirritating.
Assuntos
Cosméticos/toxicidade , Hidróxidos/toxicidade , Irritantes/toxicidade , Animais , Qualidade de Produtos para o Consumidor , Cosméticos/química , Cosméticos/farmacocinética , Humanos , Hidróxidos/química , Hidróxidos/farmacocinética , Irritantes/química , Irritantes/farmacocinética , Medição de RiscoRESUMO
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of 5 acyl sarcosines and 9 sarcosinate salts as used in cosmetics; all of these ingredients are reported to function in cosmetics as hair conditioning agents and most also can function as surfactants-cleansing agents. The ingredients reviewed in this assessment are composed of an amide comprising a fatty acyl residue and sarcosine and are either free acids or simple salts thereof. The Panel relied on relevant new data, including concentration of use, and considered data from the previous Panel report, such as the reaction of sarcosine with oxidizing materials possibly resulting in nitrosation and the formation of N-nitrososarcosine. The Panel concluded that these ingredients are safe as used in cosmetics when formulated to be non-irritating, but these ingredients should not be used in cosmetic products in which N-nitroso compounds may be formed.
Assuntos
Cosméticos/toxicidade , Irritantes/toxicidade , Sarcosina/toxicidade , Tensoativos/toxicidade , Animais , Qualidade de Produtos para o Consumidor , Cosméticos/química , Cosméticos/farmacocinética , Humanos , Irritantes/química , Irritantes/farmacocinética , Compostos Nitrosos/química , Medição de Risco , Sais , Sarcosina/química , Sarcosina/farmacocinética , Tensoativos/química , Tensoativos/farmacocinéticaRESUMO
The Expert Panel for Cosmetic Ingredient Safety (Panel) reopened the safety assessment of Sodium Sulfate, a cosmetic ingredient that is an inorganic salt reported to function in cosmetics as a viscosity increasing agent-aqueous. The Panel reviewed the relevant new data for the ingredient, including frequency of use and concentration of use, and considered data from the previous Panel assessment. The Panel concluded that Sodium Sulfate is safe in cosmetics in the present practices of use and concentrations described in this safety assessment when formulated to be nonirritating.
Assuntos
Cosméticos/toxicidade , Irritantes/toxicidade , Sulfatos/toxicidade , Animais , Qualidade de Produtos para o Consumidor , Cosméticos/química , Cosméticos/farmacocinética , Humanos , Irritantes/química , Irritantes/farmacocinética , Medição de Risco , Sulfatos/química , Sulfatos/farmacocinéticaRESUMO
The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Phosphoric Acid and its salts (31 ingredients), which are reported to function as buffering agents, corrosion inhibitors, chelating agents, and pH adjusters in cosmetic products. The Panel reviewed data relating to the safety of these ingredients and concluded that Phosphoric Acid and its salts are safe in the present practices of use and concentration in cosmetics when formulated to be nonirritating.
Assuntos
Cosméticos/toxicidade , Irritantes/toxicidade , Ácidos Fosfóricos/toxicidade , Animais , Qualidade de Produtos para o Consumidor , Cosméticos/química , Cosméticos/farmacocinética , Humanos , Irritantes/química , Irritantes/farmacocinética , Ácidos Fosfóricos/química , Ácidos Fosfóricos/farmacocinética , Medição de Risco , Sais/química , Sais/farmacocinética , Sais/toxicidadeRESUMO
Synthetic turf fields cushioned with crumb rubber may be a source of chemical exposure to those playing on the fields. Benzothiazole (BZT) may volatilize from crumb rubber and result in inhalation exposure. Benzothiazole has been the primary rubber-related chemical found in synthetic turf studies. However, risks associated with BZT have not been thoroughly assessed, primarily because of gaps in the database. This assessment provides toxicity information for a human health risk assessment involving BZT detected at five fields in Connecticut. BZT exerts acute toxicity and is a respiratory irritant and dermal sensitizer. In a genetic toxicity assay BZT was positive in Salmonella in the presence of metabolic activation. BZT metabolism involves ring-opening and formation of aromatic hydroxylamines, metabolites with mutagenic and carcinogenic potential. A structural analogue 2-mercaptobenzothiazole (2-MBZT) was more widely tested and so is used as a surrogate for some endpoints. 2-MBZT is a rodent carcinogen with rubber industry data supporting an association with human bladder cancer. The following BZT toxicity values were derived: (1) acute air target of 110 µg/m(3) based upon a BZT RD(50) study in mice relative to results for formaldehyde; (2) a chronic noncancer target of 18 µg/m(3) based upon the no-observed-adverse-effect level (NOAEL) in a subchronic dietary study in rats, dose route extrapolation, and uncertainty factors that combine to 1000; (3) a cancer unit risk of 1.8E-07/µg-m(3) based upon a published oral slope factor for 2-MBZT and dose-route extrapolation. While there are numerous uncertainties in the BZT toxicology database, this assessment enables BZT to be quantitatively assessed in risk assessments involving synthetic turf fields. However, this is only a screening-level assessment, and research that better defines BZT potency is needed.
Assuntos
Poluentes Atmosféricos/toxicidade , Benzotiazóis/toxicidade , Carcinógenos Ambientais/toxicidade , Elastômeros/química , Exposição Ambiental/efeitos adversos , Equipamentos Esportivos/efeitos adversos , Poluentes Atmosféricos/farmacocinética , Animais , Benzotiazóis/administração & dosagem , Benzotiazóis/farmacocinética , Carcinógenos Ambientais/administração & dosagem , Carcinógenos Ambientais/farmacocinética , Humanos , Irritantes/administração & dosagem , Irritantes/farmacocinética , Irritantes/toxicidade , Mutagênicos/administração & dosagem , Mutagênicos/farmacocinética , Mutagênicos/toxicidade , Medição de Risco , Compostos Orgânicos Voláteis/administração & dosagem , Compostos Orgânicos Voláteis/farmacocinética , Compostos Orgânicos Voláteis/toxicidadeRESUMO
The purpose of this study was to evaluate the potential irritating effects and the systemic exposure level of an antibacterial ointment containing REP8839 as a single agent or in combination with mupirocin versus Bactroban Nasal in rabbits. Additionally, the reversibility of REP8839 effects during a 14-day recovery period was assessed. Five treatment groups of six male and six female New Zealand White rabbits received dose levels of 1%, 2%, and 4% REP8839, 2% Bactroban Nasal, or 2% REP8839/2% mupirocin combination. One additional group of six animals/sex served as the control and received the vehicle, Petrolatum/Softisan 649. The test article or vehicle was administered to all groups via topical administration to the external nares, twice a day (approx. 8h intervals between the doses) for 21 consecutive days, at a dose volume of 100 microL per nare/dose for a total of 400 microL per day (200 microL per nare). Two animals/sex/group were maintained for a 14-day recovery period. The external nares were reflected back and the mucosal lining was evaluated and scored for erythema and edema within 30-60 min following the first dose each day. Blood samples were collected from all animals at designated time points on Day 21 of the study to assess systemic exposure levels. Cross-sectioning of the nasal tract was conducted in all the groups for microscopic evaluation. Mucosal scoring of the nares did not reveal any edema or erythema in any of the dose groups with the antibacterial alone, with the combination product, or with Bactroban Nasal. Mean body weights and food consumption were not adversely impacted by the test articles. Minimal plasma exposure was observed in the rabbits (<5 ng/mL). The REP8839 groups did appear to have dose-responsive exposure (from below the limit of quantitation to 5 ng/mL with 1%, 2%, and 4% REP8839, respectively). Microscopic changes on the nasal sectioning noted in these animals were infrequent and considered incidental findings unrelated to administration of the test articles. In conclusion doses of up to 4% of REP8839 ointment as a single agent or 2% in the combination product, as well as 2% Bactroban Nasal, were not found to induce mucosal irritation when applied topically to the external nares twice a day for 21 consecutive days. Additionally, no delayed effects were observed in the recovery animals.
Assuntos
Antibacterianos/efeitos adversos , Diaminas/efeitos adversos , Irritantes/efeitos adversos , Mucosa Nasal/efeitos dos fármacos , Tiofenos/efeitos adversos , Administração Intranasal , Animais , Antibacterianos/administração & dosagem , Antibacterianos/sangue , Disponibilidade Biológica , Diaminas/administração & dosagem , Diaminas/sangue , Diaminas/farmacocinética , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Edema/induzido quimicamente , Eritema/induzido quimicamente , Feminino , Irritantes/administração & dosagem , Irritantes/farmacocinética , Masculino , Mupirocina/administração & dosagem , Mupirocina/efeitos adversos , Mupirocina/sangue , Mupirocina/farmacocinética , Mucosa Nasal/patologia , Nariz , Pomadas/efeitos adversos , Pomadas/farmacocinética , Coelhos , Tiofenos/administração & dosagem , Tiofenos/sangue , Tiofenos/farmacocinéticaRESUMO
HC Yellow No. 5 is a direct hair dye. Hair dyes containing HC Yellow No. 5, as "coal tar" hair dye products, are exempt from the principal adulteration provision and from the color additive provision of the Federal Food, Drug, and Cosmetic Act of 1938 when the label bears a caution statement and "patch test" instructions for determining whether the product causes skin irritation. Preliminary testing on or by individuals should be done using an open patch test that is evaluated at 48 h after application of the test material. Users, therefore, would be able to determine their individual reactions to hair dye products containing HC Yellow No. 5. Absorption of HC Yellow No. 5 is minimal through skin (< 0.2%). The oral LD(50) for rats is 555.56 mg/kg. No significant toxic effects were observed after chronic oral exposure of HD Yellow No. 5 to dogs. Mild dermal irritation, but no dermal sensitization or ocular irritation was observed in laboratory animals. Results of fertility and reproductive performance, teratology, and developmental studies were negative. HC Yellow No. 5 was found to be nonmutagenic and noncytotoxic in standard laboratory assays. A current review of the hair dye epidemiology literature identified that use of direct hair dyes, although not the focus in all investigations, appears to have little evidence of an association with cancer or other adverse events. Based on the available safety test data on HC Yellow No. 5, the Panel determined that this ingredient likely would not have carcinogenic potential as used in hair dyes. The Cosmetic Ingredient Review (CIR) Expert Panel concluded that HC Yellow No. 5 is safe as a hair dye ingredient in the practices of use and concentration as described in this safety assessment.
Assuntos
Qualidade de Produtos para o Consumidor , Tinturas para Cabelo/toxicidade , Fenilenodiaminas/toxicidade , Animais , Consenso , Tinturas para Cabelo/farmacocinética , Humanos , Irritantes/farmacocinética , Irritantes/toxicidade , Fenilenodiaminas/farmacocinética , Medição de Risco , Testes de ToxicidadeRESUMO
Each of these ingredients function as hair colorants. 5-Amino-4-Chloro-o-Cresol and 5-Amino-6-Chloro-o-Cresol are identified as oxidative hair dyes, that is, they are combined with an oxidizing agent before being applied to the hair. 6-Amino-m-Cresol, 6-Amino-o-Cresol, 4-Amino-m-Cresol, and 5-Amino-4-Chloro-o-Cresol are used in oxidative hair dyes, but it is not known if they are also used in nonoxidative (semipermanent) hair dyes. No toxicologically significant impurities are present with these two ingredients. To supplement the safety test data on these ingredients, available data on related ingredients (4-amino-2-hydroxytoluene and p-,m-, and o-aminophenol) previously found safe as used by the Cosmetic Ingredient Review (CIR) Expert Panel were summarized. 5-Amino-4-Chloro-o-Cresol and 5-Amino-6-Chloro-o-Cresol do not absorb significant ultraviolet radiation in the UVB region and none in the UVA region, although 4-Amino-m-Cresol had a symmetrical UV absorption peak at 300 nm. Percutaneous penetration of 5-Amino-4-Chloro-o-Cresol and 5-Amino-6-Chloro-o-Cresol alone was significant, but when combined with oxidative developer, skin absorption was extremely low. Both of these dyes are excreted rapidly via the urine. Repeated exposure of animal skin to 5-Amino-4-Chloro-o-Cresol and 5-Amino-6-Chloro-o-Cresol failed to produce any cumulative irritation and single exposures up to 10%were not irritating to animal skin. 5-Amino-4-Chloro-o-Cresol and 5-Amino-6-Chloro-o-Cresol combined with oxidizer were not sensitizers in guinea pig maximization tests. Ocular irritation resulted from exposure of animals to undiluted 5-Amino-4-Chloro-o-Cresol, but not to a 5%solution. Only minor irritation was observed with 5%5-Amino-6-Chloro-o-Cresol. Subchronic toxicity testing in animals using 5-Amino-4-Chloro-o-Cresol, 5-Amino-6-Chloro-o-Cresol, and 4-Amino-m-Cresol did not yield any adverse reactions. 6-Amino-m-Cresol and 4-Amino-m-Cresol were generally not mutagenic in in vitro and in vivo tests. Exposure to 5-Amino-4-Chloro-o-Cresol, 5-Amino-6-Chloro-o-Cresol, 6-Amino-m-Cresol and 4-Amino-m-Cresol from cosmetics were several orders of magnitude below developmental toxicity no-observed-adverse effect levels (NOAELs). Although irritation data on several ingredients are absent, products containing these ingredients must include a caution statement and patch test instructions for determining whether the product causes skin irritation. The Expert Panel expects that following this procedure would identify individuals who would have an adverse reaction and allow them to avoid significant exposures. These compounds, when tested alone, are moderate skin sensitizers, but when combined with the developer, these ingredients are not sensitizers in animal tests. This information, coupled with the available animal test data, supports the safety of these ingredients in oxidative hair dyes. In the absence of systemic toxicity data, however, the available data are insufficient to support the safety of 6-Amino-o-Cresol and 4-Chloro-2-Aminophenol in semipermanent hair dyes. The types of data required for these two ingredients for this use include (1) physical and chemical properties, including the octanol/water partition coefficient; (2) impurities data, especially regarding the presence of m-cresol, other organic molecules, and heavy metals; (3) data demonstrating that the metabolism is similar to that of 4-amino-2-hydroxytoluene and/or p-,m-, and o-aminophenol, or 28-day dermal toxicity with histopathology, dermal reproductive toxicity data, and an in vitro genotoxicity study for 6-Amino-o-Cresol and one genotoxicity study in a mammalian system; if positive, a 2-year dermal carcinogenicity study using National Toxicology Program methods may be needed.
Assuntos
Clorofenóis/toxicidade , Qualidade de Produtos para o Consumidor , Cresóis/toxicidade , Tinturas para Cabelo/toxicidade , Animais , Clorofenóis/classificação , Clorofenóis/farmacocinética , Cresóis/classificação , Cresóis/farmacocinética , Tinturas para Cabelo/classificação , Tinturas para Cabelo/farmacocinética , Humanos , Irritantes/classificação , Irritantes/farmacocinética , Irritantes/toxicidade , Nível de Efeito Adverso não Observado , Medição de Risco , Absorção Cutânea/efeitos dos fármacosRESUMO
Cell culture methods are being developed to assess the dermal toxicity (irritancy and corrosion) of chemicals. These in vitro methods are being validated to categorize chemicals as irritating or non-irritating to humans. Currently, these cell culture tests are useful to assist in the ranking of chemicals for irritancy, but they are not useful for quantitative risk assessment for two reasons. First, for volatile chemicals the amount of chemical in the media that the cells are exposed to may decrease with exposure time. Also, effective concentrations such as EC(50) and IC(50) are reported as the concentrations in the media not the skin tissue/cells. We have developed an in vitro approach for dermal toxicity testing of volatile chemicals that avoids these problems. Using sealed vials lacking a headspace, dermal equivalents (dermal fibroblasts in a collagen matrix) were exposed to culture medium containing a test chemical (m-xylene) and compared to a traditional open well culture system. We found that about 90% of the m-xylene was lost from the open well plates and the viability was 4-6 times greater than in the closed system. Partition coefficients were measured and used to estimate the m-xylene concentration in the fibroblasts. The EC(50) for m-xylene in the dermal equivalents was 833.13+/-35.33 microg m-xylene per gram of fibroblasts. This method will provide an effective approach to relate target cell chemical concentration to cellular responses. Based on this method, a biologically-based mathematical model could be used to determine an equivalent external dose for a specific toxic end point.